MedTrace Logo

Effect of Diuretics Withdrawal in Chronic Heart Failure with Reduced Ejection Fraction

NCT05964738 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2024-11-04

No results posted yet for this study

Summary

REDICAE trial was designed to evaluate the safety and tolerability of diuretics withdrawal in stable, euvolemic chronic outpatients with heart failure with reduced ejection fraction. It is a single-center, randomized, open-label, phase II clinical trial.

Conditions

Interventions

DRUG

Diuretics withdrawal

Diuretics that not have been demonstrated improve survival in chronic HFrEF are withdrawn

DRUG

Diuretics maintenance

Any diuretic could be used

Sponsors & Collaborators

  • Sociedad Andaluza de Cardiología

    collaborator UNKNOWN

  • Maimónides Biomedical Research Institute of Córdoba

    lead OTHER

Principal Investigators

  • Alberto Torres Zamudio, MD · Hospital Universitario Reina Sofía de Córdoba

  • Juan Carlos Castillo Domínguez, MD, PhD · Maimónides Biomedical Research Institute of Córdoba

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-19
Primary Completion
2024-10-31
Completion
2024-10-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05964738 on ClinicalTrials.gov